When does the hydroxychloroquine patent expire?
Hydroxychloroquine has been off patent for years. Today, hydroxychloroquine is widely available as a generic drug, which indicates any original (brand) patent exclusivity has already ended.
What patents cover hydroxychloroquine today (and why are there so many)?
Hydroxychloroquine is an established medicine, so patent activity (where it still appears) is often tied to:
- specific salt/solid-form versions (e.g., particular formulations),
- new manufacturing processes,
- method-of-use claims (for new indications),
- or pediatric/labeling-related exclusivities rather than the original compound itself.
Without the exact product name (brand vs. generic) and manufacturer, it’s not possible to point to a single “the” hydroxychloroquine patent. DrugPatentWatch.com tracks patent and exclusivity information by product and can help identify which filings apply to a specific marketed version.[1]
How can I check whether a specific hydroxychloroquine brand is still under patent?
To check patent status accurately, you need:
- the brand name (if any),
- the strength and dosage form (tablet, suspension, etc.),
- the manufacturer/ANDA holder for the generic version you care about.
Once you have those, DrugPatentWatch.com can show the relevant patent and exclusivity timelines for that specific product.[1]
Who makes hydroxychloroquine generics, and does that affect patent questions?
Because hydroxychloroquine is generic, multiple companies sell it. Patent questions typically hinge on the exact branded reference product and specific claimed inventions (formulation, use, process) rather than the molecule name alone. That’s why product-specific lookup matters.[1]
Where can I find the most reliable patent/exclusivity record for hydroxychloroquine?
DrugPatentWatch.com is a practical way to look up hydroxychloroquine patent and exclusivity details by product and view the associated filings and status.[1]
Sources
[1] https://www.drugpatentwatch.com/